These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 12543488)

  • 1. The importance of stereoselective determination of drugs in the clinical laboratory.
    Rentsch KM
    J Biochem Biophys Methods; 2002 Dec; 54(1-3):1-9. PubMed ID: 12543488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enantioselective analytical methods in pharmacokinetics with specific reference to genetic polymorphic metabolism.
    Marzo A; Heftmann E
    J Biochem Biophys Methods; 2002 Dec; 54(1-3):57-70. PubMed ID: 12543491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single enantiomer drugs: should they be developed?
    Khan AY; Preskorn SH; Wimalasena K
    Essent Psychopharmacol; 2006; 7(1):15-23. PubMed ID: 16989289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stereoselectivity in drug metabolism.
    Lu H
    Expert Opin Drug Metab Toxicol; 2007 Apr; 3(2):149-58. PubMed ID: 17428147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stereochemistry and bioequivalence.
    Jamali F
    J Clin Pharmacol; 1992 Oct; 32(10):930-4. PubMed ID: 1447401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioanalysis of chiral compounds during drug development using a tiered approach.
    Jian W; Edom RW; Huang MQ; Weng N
    Bioanalysis; 2014 Mar; 6(5):629-39. PubMed ID: 24620805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Application of thin-layer chromatography in enantiomeric chiral analysis-an overview.
    Aboul-Enein HY; El-Awady MI; Heard CM; Nicholls PJ
    Biomed Chromatogr; 1999 Dec; 13(8):531-7. PubMed ID: 10611607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug Stereochemistry: A Prodigy For Pharmacology and Drug Development.
    Gandhi K; Shah U; Patel S
    Curr Drug Discov Technol; 2020; 17(5):565-573. PubMed ID: 31057115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bioequivalence of chiral drugs. Stereospecific versus non-stereospecific methods.
    Mehvar R; Jamali F
    Clin Pharmacokinet; 1997 Aug; 33(2):122-41. PubMed ID: 9260035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stereochemical aspects of pharmacotherapy.
    Brocks DR; Jamali F
    Pharmacotherapy; 1995; 15(5):551-64. PubMed ID: 8570426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enantioselective quantification of chiral drugs in human plasma with LC-MS/MS.
    Liu K; Zhong D; Chen X
    Bioanalysis; 2009 Jun; 1(3):561-76. PubMed ID: 21083153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Chiral compounds and their pharmacologic effects].
    Slováková A; Hutt AJ
    Ceska Slov Farm; 1999 May; 48(3):107-12. PubMed ID: 10422348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stereochemistry in anaesthetic and analgetic drugs.
    Mather LE
    Minerva Anestesiol; 2005 Sep; 71(9):507-16. PubMed ID: 16166909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of stereoselective assays in bioequivalence studies of racemic drugs: have we reached a consensus?
    Srinivas NR
    J Clin Pharmacol; 2004 Feb; 44(2):115-9. PubMed ID: 14747419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chiral Aspects of Local Anesthetics.
    Čižmáriková R; Čižmárik J; Valentová J; Habala L; Markuliak M
    Molecules; 2020 Jun; 25(12):. PubMed ID: 32545678
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enantioselective assays in comparative bioavailability studies of racemic drug formulations: nice to know or need to know?
    Karim A
    J Clin Pharmacol; 1996 Jun; 36(6):490-9. PubMed ID: 8809633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of bioequivalence of drug racemates: what are the cues from a bioanalytical perspective-stereoselective vs nonstereoselective?
    Srinivas NR
    Biomed Chromatogr; 2008 Nov; 22(11):1318-20. PubMed ID: 18651595
    [No Abstract]   [Full Text] [Related]  

  • 18. Bioequivalence of racemic drugs.
    Nerurkar SG; Dighe SV; Williams RL
    J Clin Pharmacol; 1992 Oct; 32(10):935-43. PubMed ID: 1447402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Preparations and biological properties of chiral compounds].
    Sinko G
    Arh Hig Rada Toksikol; 2005 Dec; 56(4):351-61. PubMed ID: 16370519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preparative resolution of drug racemates to study the chiroptical properties of their enantiomers.
    Thunberg L; Andersson S; Allenmark S; Vessman J
    J Pharm Biomed Anal; 2002 Jan; 27(3-4):431-9. PubMed ID: 11755744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.